SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPNPR Newswire • 7 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of...
Share to Feed
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN Get Free Report) VP Padmanabh P. Bhatt sold 14,491 shares of the companys stock in a transaction dated Thursday, March 21st. The stock was...
This is a signal that SUPN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that SUPN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that SUPN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN Get Free Report) VP Padmanabh P. Bhatt sold 3,884 shares of Supernus Pharmaceuticals stock in a transaction on Tuesday, March 12th. The stock was...
This is a signal that SUPN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN Get Free Report) VP Padmanabh P. Bhatt sold 3,884 shares of the firms stock in a transaction dated Tuesday, March 12th. The shares were sold...
This is a signal that SUPN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
ROCKVILLE, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...